| Enzyme responsive drug delivery systems in cancer treatment M Shahriari, M Zahiri, K Abnous, SM Taghdisi, M Ramezani, M Alibolandi Journal of controlled release 308, 172-189, 2019 | 256 | 2019 |
| SELEX methods on the road to protein targeting with nucleic acid aptamers P Bayat, R Nosrati, M Alibolandi, H Rafatpanah, K Abnous, M Khedri, ... Biochimie 154, 132-155, 2018 | 201 | 2018 |
| Aptamer-based biosensors and nanosensors for the detection of vascular endothelial growth factor (VEGF): A review S Dehghani, R Nosrati, M Yousefi, A Nezami, F Soltani, SM Taghdisi, ... Biosensors and Bioelectronics 110, 23-37, 2018 | 165 | 2018 |
| In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer M Alibolandi, M Ramezani, K Abnous, F Sadeghi, F Atyabi, M Asouri, ... Journal of Controlled Release 209, 88-100, 2015 | 151 | 2015 |
| Targeted doxorubicin-loaded mesenchymal stem cells-derived exosomes as a versatile platform for fighting against colorectal cancer E Bagheri, K Abnous, SA Farzad, SM Taghdisi, M Ramezani, M Alibolandi Life sciences 261, 118369, 2020 | 150 | 2020 |
| Silica based hybrid materials for drug delivery and bioimaging E Bagheri, L Ansari, K Abnous, SM Taghdisi, F Charbgoo, M Ramezani, ... Journal of Controlled Release 277, 57-76, 2018 | 148 | 2018 |
| Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: in vitro and in vivo evaluation M Alibolandi, K Abnous, F Sadeghi, H Hosseinkhani, M Ramezani, ... International Journal of Pharmaceutics 500 (1-2), 162-178, 2016 | 144 | 2016 |
| Gold nanoparticle should understand protein corona for being a clinical nanomaterial F Charbgoo, M Nejabat, K Abnous, F Soltani, SM Taghdisi, M Alibolandi, ... Journal of controlled release 272, 39-53, 2018 | 136 | 2018 |
| Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery S Taghavi, M Ramezani, M Alibolandi, K Abnous, SM Taghdisi Cancer letters 400, 1-8, 2017 | 134 | 2017 |
| Peptide-based targeted therapeutics: Focus on cancer treatment F Araste, K Abnous, M Hashemi, SM Taghdisi, M Ramezani, M Alibolandi Journal of controlled release 292, 141-162, 2018 | 132 | 2018 |
| Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo M Alibolandi, SM Taghdisi, P Ramezani, FH Shamili, SA Farzad, ... International journal of pharmaceutics 519 (1-2), 352-364, 2017 | 131 | 2017 |
| Epithelial cell adhesion molecule aptamer conjugated PEG–PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro M Alibolandi, M Ramezani, F Sadeghi, K Abnous, F Hadizadeh International journal of pharmaceutics 479 (1), 241-251, 2015 | 130 | 2015 |
| Dextran-b-poly (lactide-co-glycolide) polymersome for oral delivery of insulin: In vitro and in vivo evaluation M Alibolandi, F Alabdollah, F Sadeghi, M Mohammadi, K Abnous, ... Journal of controlled release 227, 58-70, 2016 | 125 | 2016 |
| Fabrication of aptamer decorated dextran coated nano-graphene oxide for targeted drug delivery M Alibolandi, M Mohammadi, SM Taghdisi, M Ramezani, K Abnous Carbohydrate polymers 155, 218-229, 2017 | 124 | 2017 |
| A new amplified π-shape electrochemical aptasensor for ultrasensitive detection of aflatoxin B1 K Abnous, NM Danesh, M Alibolandi, M Ramezani, AS Emrani, ... Biosensors and Bioelectronics 94, 374-379, 2017 | 117 | 2017 |
| Immunomodulatory properties of MSC-derived exosomes armed with high affinity aptamer toward mylein as a platform for reducing multiple sclerosis clinical score FH Shamili, M Alibolandi, H Rafatpanah, K Abnous, M Mahmoudi, ... Journal of Controlled Release 299, 149-164, 2019 | 111 | 2019 |
| Dextran-poly lactide-co-glycolide polymersomes decorated with folate-antennae for targeted delivery of docetaxel to breast adenocarcinima in vitro and in vivo M Alibolandi, K Abnous, F Hadizadeh, SM Taghdisi, F Alabdollah, ... Journal of controlled release 241, 45-56, 2016 | 111 | 2016 |
| Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine M Mohammadi, M Ramezani, K Abnous, M Alibolandi International journal of pharmaceutics 519 (1-2), 287-303, 2017 | 104 | 2017 |
| AS1411 aptamer-decorated biodegradable polyethylene glycol–poly (lactic-co-glycolic acid) nanopolymersomes for the targeted delivery of gemcitabine to non–small cell lung … M Alibolandi, M Ramezani, K Abnous, F Hadizadeh Journal of pharmaceutical sciences 105 (5), 1741-1750, 2016 | 102 | 2016 |
| Encapsulation of thermo-responsive gel in pH-sensitive polymersomes as dual-responsive smart carriers for controlled release of doxorubicin F Oroojalian, M Babaei, SM Taghdisi, K Abnous, M Ramezani, ... Journal of controlled release 288, 45-61, 2018 | 101 | 2018 |
Mohammad RamezaniDistinguished Professor of Pharmaceutical Biotechnology, Pharmaceutical Research Center, School ofVerified email at mums.ac.ir
